International and intergovernmental organisations

Drugs companies asked to maintain a six-week stockpile for six months in the event of ‘no-deal’ Brexit

Pharmaceutical companies have been asked to maintain a rolling six-week stockpile of medicines for six months in the event of a ‘no-deal’ Brexit, the government has confirmed.…

Pharmacy negotiators urge DHSC to allow pharmacies to trade stock without wholesale licence after Brexit

Pharmacists should be allowed to exchange stocks of medicines to mitigate local medicines shortages after Brexit, pharmacy leaders have said.…

Medicines could be delayed at the UK/EU border for six months under a ‘no-deal’ Brexit, warns DHSC

The government has warned the health and social care sector that medicines could be delayed at the UK border for a period of up to six months in the event of a ‘no-deal’ Brexit.…

Government commits to review of e-cigarette regulations after Brexit

The government has committed to reviewing how its regulations on e-cigarettes could be changed after the UK leaves the EU as scheduled for March 2019.…

Pharmacy should take Brexit lead

As discussions continue over the relationship the UK will have with the EU, pharmacy bodies must do what they can to protect the interests of patients, whichever form of Brexit emerges.…

Refrigeration for ‘no-deal’ Brexit medicine stockpiles to cost tens of millions of pounds, says Hancock

Building refrigeration capacity to store stockpiles of medicines in the event of a ‘no-deal’ Brexit is expected to cost in the “low tens of millions” of pounds, the health and social care secretary has said.…

Brexit proposals only promises ‘possibility’ of ties with EMA

The Brexit political agreement does not guarantee ties with the European Medicines Agency, despite government ministers emphasising the importance of the need for close relationships with the drugs safety organisation in 2017.…

More EMA staff expected to move to Amsterdam

The European Medicines Agency will lose fewer staff than feared when it moves from its London headquarters to a new home in Amsterdam after Brexit.…

EMA confirms suspension or restriction of quinolone and fluoroquinolone antibiotics

The marketing authorisation of medicines containing cinoxacin, flumequine, nalidixic acid and pipemidic acid should be suspended and the use of the remaining fluoroquinolone antibiotics restricted, the European Medicines Agency has concluded following a 21-month review.…

Pharmacists need not dispense European prescriptions after no-deal Brexit, argues General Pharmaceutical Council

Pharmacists need not dispense prescriptions issued in another European country in the event of a ‘no-deal’ Brexit, the General Pharmaceutical Council has argued.…